Clinical Trials

RECRUITING
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
Background: Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In t...
Conditions:
Stomach Neoplasms Stomach Cancer
Locations:
📍 Bethesda, Maryland, United States
RECRUITING
Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation
Sexual and gender minority (SGM) individuals experience significant cancer-related health disparities across the cancer continuum. The overall goal of...
Conditions:
Cancer Surveillance
Locations:
📍 Columbus, Ohio, United States
RECRUITING
CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed
This phase I trial tests the safety and best dose of CC-486 (an oral form of azacitidine) when given together with nivolumab in treating patients with...
Conditions:
Recurrent Classic Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma
Locations:
📍 Duarte, California, United States
RECRUITING
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions
The purpose of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound (CE-EUS) improves the evaluation of pancreas tu...
Conditions:
Pancreatitis Pancreas Cancer Pancreas Cyst
Locations:
📍 Los Angeles, California, United States
RECRUITING
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
This phase II trial studies if talazoparib works in patients with cancer that has spread to other places in the body (advanced) and has mutation(s) in...
Conditions:
Advanced Pancreatic Carcinoma Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Castration-Resistant Prostate Carcinoma
23 more conditions available...
Locations:
📍 Gainesville, Florida, United States
📍 Bethesda, Maryland, United States
📍 Bethesda, Maryland, United States
📍 Oklahoma City, Oklahoma, United States
RECRUITING
Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
This phase II trial tests whether decitabine and cedazuridine (ASTX727) in combination with venetoclax work better than ASTX727 alone at decreasing sy...
Conditions:
Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Myeloproliferative Neoplasm
Locations:
📍 Costa Mesa, California, United States
📍 Laguna Hills, California, United States
📍 Los Angeles, California, United States
📍 Los Angeles, California, United States
22 more locations available...
RECRUITING
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
The purpose of this study is to evaluate the safety and clinical activity of tislelizumab (an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/...
Conditions:
Pancreatic Cancer
Locations:
📍 Baltimore, Maryland, United States
RECRUITING
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
This clinical trial evaluates automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) for the screening of women who have undergone breast r...
Conditions:
Malignant Breast Neoplasm
Locations:
📍 Philadelphia, Pennsylvania, United States
RECRUITING
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
This phase I trial studies a new imaging technique called FAPi PET/CT to determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulate...
Conditions:
Breast Carcinoma Colon Carcinoma Esophageal Carcinoma Gastric Carcinoma
7 more conditions available...
Locations:
📍 Los Angeles, California, United States
RECRUITING
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced soli...
Conditions:
HER2-positive Advanced Solid Tumor
Locations:
📍 Cerritos, California, United States
📍 Los Angeles, California, United States
📍 Washington, District of Columbia, United States
📍 Coral Springs, Florida, United States
73 more locations available...
RECRUITING
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung Cance...
Conditions:
Non Small Cell Lung Cancer KRAS Activating Mutation Advanced Cancer Metastatic Cancer
2 more conditions available...
Locations:
📍 San Francisco, California, United States
📍 Aurora, Colorado, United States
📍 Jacksonville, Florida, United States
📍 Rochester, Minnesota, United States
4 more locations available...
RECRUITING
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
Background: Endometrial cancer (EC) of the uterus is becoming more common in the US. Sometimes EC often has increased levels of a protein called HER2...
Conditions:
Endometrial Cancer Cancer of Endometrium Carcinoma of Endometrium Endometrial Carcinoma
Locations:
📍 Bethesda, Maryland, United States
RECRUITING
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
The purpose of this study is to better understand how the immune system plays a role in fighting breast cancer and specifically research if the immune...
Conditions:
Breast Cancer
Locations:
📍 Dallas, Texas, United States
📍 Dallas, Texas, United States
RECRUITING
GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies
The drug that will be investigated in the study is an antibody, GEN3014. Since this is the first study of GEN3014 in humans, the main purpose is to ev...
Conditions:
Relapsed or Refractory Multiple Myeloma (RRMM) Diffuse Large B Cell Lymphoma (DLBCL) Acute Myeloid Leukemia (AML)
Locations:
📍 Hackensack, New Jersey, United States
📍 Cleveland, Ohio, United States
📍 Milwaukee, Wisconsin, United States
📍 Epping, Australia
48 more locations available...
NOT_YET_RECRUITING
Testing ONC201 to Prevent Colorectal Cancer
This phase I trial tests the safety, side effects, and best dose of Akt/ERK Inhibitor ONC201 (ONC201) in preventing colorectal cancer in patients with...
Conditions:
Colorectal Adenomatous Polyp Colorectal Carcinoma Familial Adenomatous Polyposis Multiple Adenomatous Polyps
Locations:
📍 Ann Arbor, Michigan, United States
📍 Saint Louis, Missouri, United States
📍 Cleveland, Ohio, United States
📍 Columbus, Ohio, United States
1 more location available...

Total Trials: 16 - 30 of 6772